Regulation of autocrine fibroblast growth factor-2 signaling by perfusion flow in 3D human mesenchymal stem cell constructs

Biotechnology Progress

Volumn 28, Issue 5, 2012, Pages 1384-1388

  Kim, Junho ^a   Ma, Teng ^a  

^a FAMU FSU COLLEGE OF ENGINEERING   (United States)

Author keywords

Autocrine fibroblast growth factor 2; Flow configuration; Human mesenchymal stem cells; PD173074; Perfusion bioreactor

Indexed keywords

FIBROBLAST GROWTH FACTOR-2; FLOW CONFIGURATIONS; HUMAN MESENCHYMAL STEM CELLS; PD173074; PERFUSION BIOREACTOR;

BIOCONVERSION; BIOMECHANICS; BIOREACTORS; CELL CULTURE; POLYETHYLENE TEREPHTHALATES; STEM CELLS; THREE DIMENSIONAL COMPUTER GRAPHICS;

SCAFFOLDS (BIOLOGY);

FIBROBLAST GROWTH FACTOR 2;

ARTICLE; AUTOCRINE EFFECT; BIOREACTOR; CULTURE TECHNIQUE; CYTOLOGY; EVALUATION; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; METHODOLOGY; PERFUSION; TISSUE ENGINEERING;

AUTOCRINE COMMUNICATION; BIOREACTORS; CELL CULTURE TECHNIQUES; FIBROBLAST GROWTH FACTOR 2; HUMANS; MESENCHYMAL STROMAL CELLS; PERFUSION; TISSUE ENGINEERING;

EID: 84867403469     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.1604     Document Type: Article

References (33)

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143-147.
2. Prockop DJ. Marrow stromal cells as steam cells for nonhematopoietic tissues. Science 1997; 276: 71-74.
3. Caplan AI, Dennis JE. Mesenchymal stem cells as trophic mediators. J Cell Biochem. 2006; 98: 1076-1084.
4. Coutu DL, Galipeau J. Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging-Us. 2011; 3: 920-933.
5. Tasso R, Gaetani M, Molino E, Cattaneo A, Monticone M, Bachi A, Cancedda R. The role of bFGF on the ability of MSC to activate endogenous regenerative mechanisms in an ectopic bone formation model. Biomaterials 2012; 33: 2086-2096.
6. Bianchi G, Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L, Cancedda R, Quarto R. Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res. 2003; 287: 98-105.
7. Solchaga LA, Penick K, Porter JD, Goldberg VM, Caplan AI, Welter JF. FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells. J Cell Physiol. 2005; 203: 398-409.
8. Rider DA, Dombrowski C, Sawyer AA, Ng GHB, Leong D, Hutmacher DW, Nurcombe V, Cool SM. Autocrine fibroblast growth factor 2 increases the multipotentiality of human adipose-derived mesenchymal stem cells. Stem Cells. 2008; 26: 1598-1608.
9. Zaragosi LE, Ailhaud G, Dani C. Autocrine fibroblast growth factor 2 signaling is critical for self-renewal of human multipotent adipose-derived stem cells. Stem Cells. 2006; 24: 2412-2419.
10. Fannon M, Forsten KE, Nugent MA. Potentiation and inhibition of bFGF binding by heparin: a model for regulation of cellular response. Biochemistry. 2000; 39: 1434-1445.
11. Dowd CJ, Cooney CL, Nugent MA. Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J Biol Chem. 1999; 274: 5236-5244.
12. Filion RJ, Popel AS. A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors. Ann Biomed Eng. 2004; 32: 645-663.
13. Burdick JA, Vunjak-Novakovic G. Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A. 2009; 15: 205-219.
14. Kim J, Ma T. Perfusion regulation of hMSC microenvironment and osteogenic differentiation in 3D scaffold. Biotechnol Bioeng. 2012; 109: 252-261.
15. Zhao F, Ma T. Perfusion bioreactor system for human mesenchymal stem cell tissue engineering: dynamic cell seeding and construct development. Biotechnol Bioeng. 2005; 91: 482-493.
16. Zhao F, Chella R, Ma T. Effects of shear stress on 3-D human mesenchymal stem cell construct development in a versatile perfusion bioreactor system: experiments and hydrodynamic modeling. Biotechnol Bioeng. 2007; 96: 584-595.
17. Li Y, Ma T, Yang S, Kniss D. Thermal compression and characterization of three-dimensional nonwoven PET matrices as tissue engineering scaffolds. Biomaterials. 2001; 22: 609-618.
18. Skaper SD, Kee WJ, Facci L, MacDonald G, Doherty P, Walsh FS. The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects. J Neurochem. 2000; 75: 1520-1527.
19. Zhao F, Grayson WL, Ma T, Irsigler A. Perfusion affects the tissue developmental patterns of human mesenchymal stem cells in 3D scaffolds. J Cell Physiol. 2009; 219: 421-429.
20. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science. 2009; 324: 1673-1677.
21. Lee RH, Oh JY, Choi H, Bazhanov N. Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem. 2011; 112: 3073-3078.
22. Mohammadi M, Froum S, Hamby JM, Schroeder MC, Panek RL, Lu GH, Eliseenkova AV, Green D, Schlessinger J, Hubbard SR. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain. EMBO J. 1998; 17: 5896-5904.
23. Bansal R, Magge S, Winkler S. Specific inhibitor of FGF receptor signaling: FGF-2-mediated effects on proliferation, differentiation, and MAPK activation are inhibited by PD173074 in oligodendrocyte-lineage cells. J Neurosci Res. 2003; 74: 486-493.
24. Schmidt A, Ladage D, Schinkothe T, Klausmann U, Ulrichsa C, Klinz FJ, Brixius K, Arnhold S, Desai B, Mehlhorn U, Schwinger RHG, Staib P, Addicks K, Bloch W. Basic fibroblast growth factor controls migration in human mesenchymal stem cells. Stem Cells. 2006; 24: 1750-1758.
25. Chen XD, Dusevich V, Feng JQ, Manolagas SC, Jilka RL. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts. J Bone Mineral Res. 2007; 22: 1943-1956.
26. van den Bos C, Mosca JD, Winkles J, Kerrigan L, Burgess WH, Marshak DR. Human mesenchymal stem cells respond to fibroblast growth factors. Hum. Cell 1997; 10: 45-50.
27. Oliver LJ, Rifkin DB, Gabrilove J, Hannocks MJ, Wilson EL. Long-term culture of human bone marrow stromal cells in the presence of basic fibroblast growth factor. Growth Factors. 1990; 3: 231-236.
28. Sensebe L, Krampera M, Schrezenmeier H, Bourin P, Giordano R. Mesenchymal stem cells for clinical application. Vox Sang. 2010; 98: 93-107.
29. Hudalla GA, Kouris NA, Koepsel JT, Ogle BM, Murphy WL. Harnessing endogenous growth factor activity modulates stem cell behavior. Integr Biol (Camb). 2011; 3: 832-842.
30. McCoy RJ, O'Brien FJ. Influence of shear stress in perfusion bioreactor cultures for the development of three-dimensional bone tissue constructs: a review. Tissue Eng Part B-Rev. 2010; 16: 587-601.
31. McCoy RJ, Jungreuthmayer C, O'Brien FJ. Influence of flow rate and scaffold pore size on cell behavior during mechanical stimulation in a flow perfusion bioreactor. Biotechnol Bioeng. 2012; 109: 1583-1594.
32. Grayson WL, Ma T, Bunnell B. Human mesenchymal stem cells tissue development in 3D PET matrices. Biotechnol Prog. 2004; 20: 905-912.
33. Griffith LG, Swartz MA. Capturing complex 3D tissue physiology in vitro. Nat Rev Mol Cell Biol. 2006; 7: 211-224.